Skip to main content

Afebrile benign convulsions with or without a reversible splenial lesion in two pediatric patients with COVID-19



Seizures in children with coronavirus disease 2019 (COVID-19) were markedly increased during the Omicron variant surge. Most seizures occurred with fever. New-onset afebrile seizures were rarely reported; therefore, their courses are not well-known.

Case presentation

Two patients (7 and 26 months of age, respectively) with COVID-19 showed recurrent afebrile seizures immediately after resolution of a fever lasting for 2–3 days. Bilateral convulsive seizures lasted for approximately 1 min/episode (6 of 7 total episodes) and occurred 3–4 times within 2–3 h. However, the patients were alert between seizures, which is in contrast to seizures occurring with encephalopathy or encephalitis. Only one episode required acute antiseizure medication. Brain magnetic resonance imaging showed a reversible splenial lesion in one patient. The serum uric acid level was slightly increased (7.8 mg/dL) in this patient. Electroencephalography findings were all normal. During the follow-up period, no seizures or developmental problems have been observed.


COVID-19-associated, afebrile benign convulsions with or without a reversible splenial lesion are similar to ‘benign convulsions with mild gastroenteritis’; therefore, continuation of antiseizure medication does not seem necessary.

Peer Review reports


Children with coronavirus disease 2019 (COVID-19) present with diverse neurologic symptoms or signs [1,2,3,4,5,6,7,8,9]. Specific neurologic issues, such as seizures, meningeal irritation, and mental changes, have been reported more frequently in more critically ill patients [3, 8, 9]. Neurologic diseases reported in pediatric patients with COVID-19 include convulsive diseases, encephalitis or encephalopathy, demyelinating diseases, cerebral ischemic or hemorrhagic stroke, and cranial nerve palsy [1,2,3,4,5,6,7,8]. The proportion of seizures among all children admitted to the hospital with COVID-19 was estimated to be < 10% before the Omicron variant surge but increased up to 20% after the outbreak [8, 10,11,12,13]. Before the Omicron variant surge, most seizures were reported not as isolated diseases but as additional signs in a febrile period associated with other major inflammatory diseases [3, 7]. Only Kurd et al. have reported that seizures were the main manifestation during the early stages of COVID-19 in some children (6.2% of 175 children visiting an emergency department) [4]. During the Omicron variant surge in early 2022, approximately 69–85% of seizures were reported as febrile convulsions or provoked seizures during a febrile period [10,11,12]. New-onset, afebrile seizures in previously healthy pediatric patients with COVID-19 are uncommon, especially those with a reversible splenial lesion. In addition, their treatment and prognosis are rarely described in detail. Here, we reported two patients with afebrile benign convulsions associated with COVID-19 during the Omicron variant outbreak in South Korea (between March and April 2022). One of the patients had a reversible splenial lesion, which is rarely reported in patients with COVID-19; in particular, there are no reports of such lesions in those without encephalopathy. Their clinical characteristics were similar to those observed in young children with benign convulsions with mild gastroenteritis (CwG) due to rotavirus or norovirus [14,15,16,17,18].

Case presentation

Case 1

A 7-month-old male infant with COVID-19 visited the emergency room (ER) due to new-onset recurrent seizures without a fever. Before seizure onset, he had experienced a fever, cough, and intermittent vomiting for three days. He was diagnosed with COVID-19 via polymerase chain reaction (PCR) sequencing of nasal and throat swabs on the second febrile day. Prior to his diagnosis, his mother was diagnosed with COVID-19. On the 4th day when the fever had subsided, seizures suddenly developed. This patient was previously healthy, had an uneventful birth at a gestational age of 38 weeks and weighing 3,580 g, and had unrelated parents. No family members had seizures or developmental problems.

He had brief bilateral tonic-clonic seizures (4 episodes within 2 h). Each episode lasted for approximately 1 min and was associated with upward eyeball deviation, crying, and facial flushing. There was no change in his mental state between episodes, in contrast to cases of encephalopathy or encephalitis. Brain computed tomography, electrocardiography (EKG), chest roentgenography, and basic laboratory tests including measurement of serum glucose, electrolytes, and uric acid levels were all normal. Brain magnetic resonance imaging (MRI) was not available for patients with mild symptoms at that time. The patient had no more seizures or fever in a negative-pressure isolation room; therefore, he was discharged that day. At follow-up 10 days later in the outpatient clinic, his growth and development were normal. Brain MRI and electroencephalography (EEG) were performed within 30 days of the onset of his first seizure. The results were all normal (Table 1). During the one-year follow-up period, no seizures or developmental problems were observed.

Table 1 Characteristics of patients with COVID-19-associated afebrile benign convulsions

Case 2

A 26-month-old male patient with COVID-19 was transferred to the ER due to two events of new-onset brief tonic seizures without a fever (approximately 1 min/episode). Prior to his seizures, he and his family members were diagnosed with COVID-19. COVID-19 was confirmed on the first febrile day via PCR sequencing using samples from his nose and throat. He had been febrile for the previous two days, but was not febrile on the 3rd day when his seizures developed. He was previously healthy with normal development and growth. He was born without any specific perinatal events at a gestational age of 37 weeks from unrelated healthy parents and weighed 3,000 g. There was no history of seizures or developmental disorders in his family.

His third seizure was observed three hours after the first seizure onset in the ER; it was a bilateral tonic-clonic seizure and lasted for 10 min even with two injections of lorazepam. However, fosphenytoin administration was successful at controlling the seizure. Although the patient briefly lost awareness during the seizures, he became alert between and after seizures, in contrast to seizures associated with encephalopathy. He recovered quickly even after antiseizure medication. Chest roentgenography, EKG, and most basic laboratory tests performed in the ER were all normal, except for a slightly increased serum uric acid level (7.8 mg/dL). Brain MRI on admission showed a 1-cm T2-hyperintense lesion with diffusion restriction in the splenium of the corpus callosum (Fig. 1. A–C). His general condition was relatively good without seizures or a fever in a negative-pressure isolation room; therefore, he was discharged the next day without medication. At a follow-up visit, brain diffusion-weighted MRI that was performed 47 days later revealed no nodular diffusion-restricted lesions in the corpus callosal splenium (Fig. 1. D). An EEG performed during sleep on the same day was normal (Table 1). During the one-year follow-up period, seizures did not recur. The patient developed normally.

Fig. 1
figure 1

Brain magnetic resonance imaging (MRI) at the time of diagnosis (A–C) and 47 days after the first visit (D) in patient 2. Axial T2-weighted (A) and fluid-attenuated inversion recovery (FLAIR, B) images showed a 1-cm hyperintense lesion in the splenium of the corpus callosum. This lesion with diffusion restriction (C) on diffusion imaging at the time of diagnosis was not detected in the corpus callosal splenium 47 days after the first visit (D)

Discussion and conclusions

The two children with COVID-19 described in this report presented with recurrent, brief, afebrile convulsions. They visited our hospital during the Omicron variant waves; however, further laboratory confirmation of the Omicron variant was not available commercially. They were aged 7 and 26 months, respectively, and were previously healthy with normal development. They had no family history of seizures. Seizures appeared immediately after the fever had subsided. Neither patient had mental confusion, which is in contrast to patients with encephalopathy or encephalitis. Seizures occurred 3–4 times within 2–3 h. Six out of seven seizures lasted for approximately 1 min. Only one episode lasted for 10 min and responded to fosphenytoin but not to lorazepam. The seizures were bilateral tonic-clonic or tonic. One patient showed a reversible splenial lesion on brain MRI, which has not yet been reported in patients with COVID-19 without encephalopathy. The serum uric acid level was slightly elevated in this patient (7.8 mg/dL). In the other patient, brain MRI was not available on admission. EEGs were also not available for both of these patients on admission because they were available only for critically-ill patients with COVID-19 in the intensive care unit at that time. EEGs that were performed later were all normal. These new-onset stereotyped seizures in young children showed a benign course without concomitant major infectious/inflammatory symptoms or neurologic deficits. These phenotypes and disease course were quite similar to those of CwG [14,15,16,17,18].

CwG occur sporadically in previously healthy infants and young children (typical range, 6–36 months of age) [14, 15]. Afebrile short-lasting and recurrent seizures typically occur in one day in association with enteric viral infection (e.g., rotavirus or norovirus) without hypoglycemia, electrolyte imbalances, or abnormal cerebrospinal fluid [14, 15]. However, a high serum uric acid level has been reported [15, 16]. Brain MRI and EEG are normal in most patients [14, 15], but reversible splenial lesions have been noted in some patients with CwG [17, 18]. Seizures have a good prognosis and require only transient acute antiseizure medication in some patients [14, 15]. CwG is associated with situation-related seizures and rarely with the development of epilepsy. This condition can recur as afebrile seizures associated with acute gastroenteritis in approximately 5% of cases [19].

Cloete and colleagues have summarized the characteristics of pediatric seizures during the Omicron variant wave in 25 children admitted to the hospital [10]. Twenty-one patients (84%) had uncomplicated seizures without copathology (e.g., epilepsy, cerebral palsy, hypoglycemia, or electrolyte imbalances) [10]. Among these, 17 patients (81%) had simple febrile seizures [10]. Four patients were out of the typical age range for febrile convulsions [10]. Although mild clinical impairments have been reported in children with seizures during the Omicron variant surge, most seizures with fever were benign without neurologic deficits compared with the findings of previous reports published before the outbreak [3, 8,9,10,11,12,13].

There are limited brain MRI data from patients with COVID-19 and neurologic symptoms, even adults. Splenial lesions have been reported in four children who presented with encephalopathy associated with COVID-19 pediatric multisystem inflammatory syndrome; however, none of these patients had seizures [5]. Reversible splenial lesions can be observed in diverse diseases: infections with various pathogens including viruses, seizures, systemic illnesses such as Kawasaki disease or systemic lupus erythematosus, malnutrition, intoxication (e.g., CO or metronidazole), and mountain sickness [20]. Reversible splenial lesions may be caused by intra-myelin edema due to inflammation; these typically resolve within a week [5, 20].

The pathophysiologic mechanism explaining the occurrence of seizures in patients with COVID-19 has not been clearly elucidated. However, there are some hypotheses for the occurrence of neurologic symptoms: (1) direct neuronal injury by viral invasion through the angiotensin-converting enzyme 2 (ACE2) receptor on the neuronal membrane; (2) prothrombotic state triggered by vascular endothelial injury through the ACE2 receptor on endothelial cells; and (3) postinfectious or parainfectious hyperinflammatory state, disrupting the blood-brain barrier via immune system dysregulation (e.g., cytokine storm, immune cell activation, and autoantibodies to the nervous system) [6, 7].

New-onset afebrile seizures associated with COVID-19 in previously healthy children without a family history of seizures have been rarely reported [4, 11, 13]. Here, we reported cases of two young children (< 3 years) with COVID-19 who showed new-onset brief and recurrent afebrile convulsions immediately after resolution of a fever. One of them had a reversible splenial lesion, which have rarely been reported in patients with COVID-19, particularly in those without encephalopathy. The clinical characteristics in these patients were similar to those reported in patients with CwG. Therefore, if a patient is not critically ill and remains alert between seizures, in contrast to seizures associated with encephalopathy/encephalitis, long-term antiseizure medication is not recommended.

Data Availability

Not applicable for our study.



Children with coronavirus disease 2019


Benign infantile convulsions with mild gastroenteritis


Emergency room


Polymerase chain reaction




Magnetic resonance imaging




Angiotensin-converting enzyme 2






While blood cell


Within normal limit


Fluid-attenuated inversion recovery


Diffusion weighted image


  1. LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021;78:536–47.

    Article  PubMed  Google Scholar 

  2. Ray STJ, Abdel-Mannan O, Sa M, Fuller C, Wood GK, Pysden K, et al. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study. Lancet Child Adolesc Health. 2021;5:631–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological complications of SARS-CoV-2 infection in children: a systematic review and Meta-analysis. J Trop Pediatr. 2021;67:fmaa070.

    Article  PubMed  Google Scholar 

  4. Kurd M, Hashavya S, Benenson S, Gilboa T. Seizures as the main presenting manifestation of acute SARS-CoV-2 infection in children. Seizure. 2021;92:89–93.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Abdel-Mannan O, Eyre M, Löbel U, Bamford A, Eltze C, Hameed B, et al. Neurologic and radiographic findings Associated with COVID-19 infection in children. JAMA Neurol. 2020;77:1440–5.

    Article  PubMed  Google Scholar 

  6. Valderas C, Méndez G, Echeverría A, Suarez N, Julio K, Sandoval F. COVID-19 and neurologic manifestations: a synthesis from the child neurologist’s corner. World J Pediatr. 2022;18:373–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lin JE, Asfour A, Sewell TB, Hooe B, Pryce P, Earley C, et al. Neurological issues in children with COVID-19. Neurosci Lett. 2021;743:135567.

    Article  CAS  PubMed  Google Scholar 

  8. Fink EL, Robertson CL, Wainwright MS, Roa JD, Lovett ME, Stulce C, et al. Prevalence and risk factors of neurologic Manifestations in Hospitalized Children diagnosed with Acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2022;128:33–44.

    Article  PubMed  Google Scholar 

  9. Laçinel Gürlevik S, Günbey C, Ozsurekci Y, Oygar PD, Kesici S, Gocmen R, et al. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review. Eur J Paediatr Neurol. 2022;37:139–54.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Cloete J, Kruger A, Masha M, du Plessis NM, Mawela D, Tshukudu M, et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc Health. 2022;6:294–302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Thongsing A, Eizadkhah D, Fields C, Ballaban-Gil K. Provoked seizures and status epilepticus in a pediatric population with COVID-19 disease. Epilepsia. 2022;63:e86–91.

  12. Bova SM, Serafini L, Serati I, Fiori L, Veggiotti P. Seizures may be an early sign of acute COVID-19, and the Omicron variant could present a more epileptogenic profile. Acta Paediatr. 2022;111:1814–5.

  13. Ludvigsson JF. Convulsions in children with COVID-19 during the Omicron wave. Acta Paediatr. 2022;111:1023–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kang B, Kwon YS. Benign convulsion with mild gastroenteritis. Korean J Pediatr. 2014;57:304–9.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kim BR, Choi GE, Kim YO, Kim MJ, Song ES, Woo YJ. Incidence and characteristics of norovirus-associated benign convulsions with mild gastroenteritis, in comparison with rotavirus ones. Brain Dev. 2018;40:699–706.

    Article  PubMed  Google Scholar 

  16. Yoo IH, Kim W, Cho J, Kim H, Lim BC, Hwang H, et al. Elevated serum uric acid in Benign Convulsions with mild gastroenteritis in children. J Clin Neurol. 2019;15:496–501.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Jiang L, Mao S, Xu J, Gao F. Reversible splenial lesion syndrome in children with benign convulsions associated with mild gastroenteritis: a retrospective study of five cases. Brain Dev. 2019;41:271–5.

    Article  PubMed  Google Scholar 

  18. Ogawa C, Kidokoro H, Ishihara N, Tsuji T, Kurahashi H, Hattori A, et al. Splenial lesions in Benign Convulsions with Gastroenteritis Associated with Rotavirus infection. Pediatr Neurol. 2020;109:79–84.

    Article  PubMed  Google Scholar 

  19. Wang D, Jiang Y, Hong S, Ma J, Liao S, Cheng M, et al. Prognostic factors for the recurrence of afebrile seizures after benign convulsions associated with mild gastroenteritis. Epilepsia. 2021;62:3068–75.

    Article  PubMed  Google Scholar 

  20. Kontzialis M, Soares BP, Huisman T. Lesions in the splenium of the Corpus Callosum on MRI in children: a review. J Neuroimaging. 2017;27:549–61.

    Article  PubMed  Google Scholar 

Download references


Not applicable for our study.


Not applicable for our study.

Author information

Authors and Affiliations



Young Ok Kim acquired the data, and wrote and critically revised the main manuscript and Fig. 1. Yun Young Lee drafted the main manuscript and prepared Fig. 1. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Young Ok Kim.

Ethics declarations

Consent to publish

The written informed consent was obtained from subjects and/or their legal guardians for publication.

Competing interests

The authors have no potential conflicts of interest to disclose.

Ethical approval

This study was approved by the Human Research Ethics Committee of Chonnam National University Hospital (Gwangju, South Korea; IRB number, CNUH-EXP-2022-262).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, Y.Y., Kim, Y.O. Afebrile benign convulsions with or without a reversible splenial lesion in two pediatric patients with COVID-19. BMC Pediatr 23, 198 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: